Clobetasol propionate + methotrexate (DrugBank: Methotrexate, Clobetasol propionate, Clobetasol)
4 diseases| 告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
|---|---|---|
| 39 | 中毒性表皮壊死症 | 0 |
| 46 | 悪性関節リウマチ | 0 |
| 51 | 全身性強皮症 | 0 |
| 162 | 類天疱瘡(後天性表皮水疱症を含む。) | 1 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02313870 (ClinicalTrials.gov) | January 2008 | 8/12/2014 | Topical Steroids Alone or Associated With Methotrexate in Bullous Pemphigoid | Comparison of Monotherapy With Protracted Superpotent Topical Steroids to Superpotent Topical Steroids Associated With Methotrexate in Bullous Pemphigoid | Bullous Pemphigoid | Drug: clobetasol propionate + Methotrexate;Drug: clobetasol propionate alone | University Hospital, Montpellier | NULL | Recruiting | 18 Years | N/A | Both | 300 | Phase 3 | France |